Bova A A, Lapitskiĭ D V
Klin Med (Mosk). 2009;87(2):8-13.
This review concerns peculiarities of pharmacotherapy for patients with concomitant coronary heart disease and chronic obstructive pulmonary disease. It describes the main pharmacodynamic and pharmacokinetic properties of cholinolytics, beta-agonists, methylxanthines, corticosteroids, antibiotics, ACE inhibitors, calcium channel blockers, beta-blockers, nitrates, and anti-aggregants. These data are used to substantiate the application of these drugs to the treatment of overlapping pathologies with special reference to concomitant coronary heart disease and chronic obstructive pulmonary disease.
本综述关注合并冠心病和慢性阻塞性肺疾病患者的药物治疗特点。它描述了解胆碱药、β受体激动剂、甲基黄嘌呤、皮质类固醇、抗生素、血管紧张素转换酶抑制剂、钙通道阻滞剂、β受体阻滞剂、硝酸盐和抗血小板聚集剂的主要药效学和药代动力学特性。这些数据用于证实这些药物在治疗重叠病症中的应用，特别提及合并冠心病和慢性阻塞性肺疾病的情况。
